you are viewing a single comment's thread.
Motley fool is for fools.Once a cute start up,they were bought up and now spew garbage,and collect a fee in return Ignore them
They are like any investment counselor, paid or free, Cramer, GS, etc. You have to weigh WHAT the say and WHY against your own experience and common sense.So based on that the long term prospects for Syngeva just don't look positive to me. Limited pipeline and patient base. Management that might be motivated to just milk the Trimeris cash.You? Why?
Make it simple you idiot; sell the shares you might have and leave the board !